Results 81 to 90 of about 14,207 (206)

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease [PDF]

open access: yes, 2010
Background Combination therapy (inhaled corticosteroids and long-acting beta(2)-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD).
Appleton   +20 more
core   +1 more source

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease

open access: yesDrugs in Context, 2019
Inhalation therapy is likely to continue to dominate asthma and chronic obstructive pulmonary disease (COPD) treatment. The pressurised metered-dose inhaler (pMDI) accounts for most of the global inhaler market, but this kind of device is difficult to ...
Federico Lavorini
doaj   +1 more source

[New dry powder inhalers].

open access: yesPneumonologia i alergologia polska, 2016
The most recently approved DPI's - Ellipta™ and NEXThaler® are the most modern inhalers on the market. Both are flow independent in the physiological range of flows seen in patients with asthma and/or COPD. Both require three actions (open-load -inhaler) for a successful inhalation.
Andrzej, Emeryk, Michał, Pirożyński
openaire   +1 more source

Dry Powder Inhalers: A Review

open access: yesIndo Global Journal of Pharmaceutical Sciences, 2013
In the recent years pulmonary drug delivery system is found to be preferred route of administration for various drugs. It has been divided into 3 classes: Nebulizers, pMDI, DPI.DPI are used as an alternative to pMDI because pMDI contains propellant (CFC) which has ozone depletion characteristics.
Niti Yadav, Alka Lohani
openaire   +1 more source

Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study [PDF]

open access: yes, 2014
Drug delivery from a Dry Powder Inhaler (DPI) is dependent on the peak inspiratory flow rate (PIFR) generated. Currently available methods for estimating PIFR from most DPIs are limited and mainly rely on subjective assessment.
Al Bannai, Hasan   +6 more
core   +1 more source

Asthma Control: The Right Inhaler for the Right Patient. [PDF]

open access: yes, 2015
Inhaled therapy is the cornerstone of asthma management in that it optimizes the delivery of the medication to the site of action. The effectiveness of inhaled therapy is affected by the correct choice of the device and proper inhalation technique.
SCICHILONE, Nicola Alessandro
core   +2 more sources

Asthma management: important issues

open access: yesEuropean Respiratory Review, 2005
Although most attention has been focused on the drugs used to control asthma, it is increasingly recognised that effective delivery of these drugs to the lungs is just as important.
P. Barnes   +4 more
doaj  

Advances in inhalation therapy in pediatrics [PDF]

open access: yes, 2010
OBJETIVOS: Revisar os artigos mais relevantes a respeito dos aspectos técnicos da terapêutica inalatória, dos inaladores disponíveis e principalmente dos principais avanços obtidos na inaloterapia em pediatria.
MUCHÃO, Fábio Pereira   +1 more
core   +3 more sources

Распадаемость агломератов в процессе высвобождения из ингалятора [PDF]

open access: yes, 2018
Представлены результаты экспериментальных исследований фракционного состава микронизированной активной фармацевтической субстанции Сальметерола ксинафоат при выходе из однодозового порошкового ингалятора.
Иванов, Н. А.   +2 more
core   +2 more sources

Ciprofloxacin dry powder inhaler in cystic fibrosis [PDF]

open access: yesBMJ Open Respiratory Research, 2016
Inhaled antibiotics are the backbone of care for people with cystic fibrosis (CF) who have lung infection due to Pseudomonas aeruginosa. They have significantly contributed to the improved quality of life (QOL) and increased survival in people with this disease.1 The systematic application of antibiotic eradication therapy for new or recurrent ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy